| |
|
|
|
Oxford Global, 99 City Road Conference Centre
6 - 7 November 2017
Including 3 interactive streams:
* Stem Cell Bioprocessing
* Industry Spotlight Presentations
* Stem Cell Therapy Development: Clinical Trials
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
Confirmed Stem Cell Speakers include:
* Sven Kili, Vice President and Head of Gene Therapy Development, GlaxoSmithKline
* Shailesh Gupta, Senior Scientist Bioscience, Stem & Primary Cell Group, AstraZeneca
* John Sinden, Chief Scientific Officer, ReNeuron
* Emily Titus, Director, Technology Development, Centre for Commercialization of Regenerative Medicine (CCRM)
* Susan Solomon, Chief Executive Officer and Co-Founder, New York Stem Cell Foundation
* Michaela Sharpe, Head of Non-Clinical Safety and Immunotherapy Strategy, Cell & Gene Therapy Catapult
* Nagy Habib, Professor, Imperial College of London
* Che Connon, Professor of Tissue Engineering, Newcastle University
* Anthony Ho, Professor & Chair, Department of Medicine, University of Heidelberg
* Timothy O’Brien, Director, Regenerative Medicine Institute, National University of Ireland Galway
* David Schaffer, Director, Berkeley Stem Cell Center, University of California, Berkeley
* Benedikt Berninger, Professor, University Medical Center, Johannes Gutenberg University Mainz
* Dominique Bonnet, Senior Group Leader, The Francis Crick Institute
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
For further information regarding prices and booking details, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455
|
|
|
E-mail:
|
|
g.alonso@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|